PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 62 filers reported holding PLIANT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.7%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,755,937 | -1.5% | 504,956 | +2.9% | 0.00% | 0.0% |
Q2 2023 | $8,893,133 | +222.5% | 490,791 | +373.4% | 0.00% | +100.0% |
Q1 2023 | $2,757,542 | +75.3% | 103,667 | +27.4% | 0.00% | – |
Q4 2022 | $1,572,921 | +33.8% | 81,372 | +44.5% | 0.00% | – |
Q3 2022 | $1,176,000 | +289.4% | 56,301 | +49.1% | 0.00% | – |
Q2 2022 | $302,000 | -79.8% | 37,761 | -82.3% | 0.00% | – |
Q1 2022 | $1,498,000 | -51.4% | 213,669 | -6.5% | 0.00% | -100.0% |
Q4 2021 | $3,084,000 | -18.7% | 228,451 | +1.6% | 0.00% | 0.0% |
Q3 2021 | $3,795,000 | -39.7% | 224,820 | +4.0% | 0.00% | 0.0% |
Q2 2021 | $6,293,000 | -28.0% | 216,122 | -2.7% | 0.00% | -50.0% |
Q1 2021 | $8,735,000 | +216.3% | 222,092 | +82.7% | 0.00% | +100.0% |
Q4 2020 | $2,762,000 | +0.6% | 121,536 | +0.3% | 0.00% | 0.0% |
Q3 2020 | $2,745,000 | – | 121,214 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 339,160 | $5,881,034 | 100.00% |
CHI Advisors LLC | 3,014,199 | $52,266,211 | 20.72% |
TRV GP IV, LLC | 2,132,867 | $36,983,914 | 13.93% |
GREAT POINT PARTNERS LLC | 1,755,184 | $30,434,891 | 5.54% |
First Light Asset Management, LLC | 2,933,260 | $50,862,728 | 4.83% |
Deep Track Capital, LP | 5,500,000 | $95,370,000 | 3.68% |
Casdin Capital, LLC | 1,577,108 | $27,347,053 | 3.03% |
Fernwood Investment Management, LLC | 379,702 | $6,584,033 | 2.37% |
Redmile Group, LLC | 2,678,099 | $46,438,237 | 2.21% |
SILVERARC CAPITAL MANAGEMENT, LLC | 250,409 | $4,342,092 | 1.32% |